J Neurol Surg A Cent Eur Neurosurg 2013; 74(S 01): e149-e154
DOI: 10.1055/s-0032-1333419
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Recurrent Adult Choroid Plexus Carcinoma Treated with High-Dose Chemotherapy and Syngeneic Stem Cell (Bone Marrow) Transplant

Thomas A. Samuel
1   Department of Medicine, Hematology/Oncology, Georgia Health Sciences University, Augusta, Georgia, United States
,
Jigarkumar Parikh
2   Department of Medicine, Georgia Health Sciences University, Augusta, Georgia, United States
,
Suash Sharma
3   Department of Pathology, Georgia Health Sciences University, Augusta, Georgia, United States
,
Cole A. Giller
4   Department of Neurosurgery, Georgia Health Sciences University, Augusta, Georgia, United States
,
Kristen Sterling
2   Department of Medicine, Georgia Health Sciences University, Augusta, Georgia, United States
,
Suraj Kapoor
2   Department of Medicine, Georgia Health Sciences University, Augusta, Georgia, United States
,
Christen Pirkle
2   Department of Medicine, Georgia Health Sciences University, Augusta, Georgia, United States
,
Anand Jillella
2   Department of Medicine, Georgia Health Sciences University, Augusta, Georgia, United States
› Institutsangaben
Weitere Informationen

Publikationsverlauf

08. Mai 2012

23. August 2012

Publikationsdatum:
20. Februar 2013 (online)

Abstract

Choroid plexus carcinomas (CPCs) are rare epithelial central nervous system tumors. CPC occurs mainly in infants and young children, comprising ∼1 to 4% of all pediatric brain neoplasms. There is very limited information available regarding tumor biology and CPC treatment due to its rarity. There have been various case reports and meta-analyses of reported cases with CPC. Surgical resection is often challenging but remains a well-established treatment option. Chemotherapy is often reserved for recurrent or refractory cases, but the goal of treatment is usually palliative. We present a case of recurrent, adult CPC with disseminated leptomeningeal involvement treated with salvage chemotherapy including high-dose ifosfamide, carboplatin, and etoposide; once a remission was achieved, this response was consolidated with a syngeneic stem cell (bone marrow) transplant after a preparative regimen of high-dose chemotherapy with carboplatin, etoposide, and thiotepa. Although the patient tolerated the transplant well and remained disease-free for 12 months, she subsequently succumbed to relapsed disease 18 months posttransplant. We believe that this is the first report of using syngeneic stem cell transplant in CPC to consolidate a remission achieved by salvage chemotherapy.

 
  • References

  • 1 Wrede B, Liu P, Wolff JE. Chemotherapy improves the survival of patients with choroid plexus carcinoma: a meta-analysis of individual cases with choroid plexus tumors. J Neurooncol 2007; 85: 345-351
  • 2 Lozier AP, Arbaje YM, Scheithauer BW. Supratentorial, extraventricular choroid plexus carcinoma in an adult: case report. Neurosurgery 2009; 65: E816-E817
  • 3 Lafay-Cousin L, Keene D, Carret AS , et al. Choroid plexus tumors in children less than 36 months: the Canadian Pediatric Brain Tumor Consortium (CPBTC) experience. Childs Nerv Syst 2011; 27: 259-264
  • 4 Paulus BS. Choroid plexus tumors. In: WHO classification of tumors of the central nervous system. International Agency for Research on Cancer. 24th ed. 2007: 82-85
  • 5 Jeibmann A, Hasselblatt M, Gerss J , et al. Prognostic implications of atypical histologic features in choroid plexus papilloma. J Neuropathol Exp Neurol 2006; 65: 1069-1073
  • 6 Wrede B, Hasselblatt M, Peters O , et al. Atypical choroid plexus papilloma: clinical experience in the CPT-SIOP-2000 study. J Neurooncol 2009; 95: 383-392
  • 7 Lafay-Cousin L, Strother D. Current treatment approaches for infants with malignant central nervous system tumors. Oncologist 2009; 14: 433-444
  • 8 Wolburg H, Paulus W. Choroid plexus: biology and pathology. Acta Neuropathol 2010; 119: 75-88
  • 9 Menon G, Nair SN, Baldawa SS, Rao RB, Krishnakumar KP, Gopalakrishnan CV. Choroid plexus tumors: an institutional series of 25 patients. Neurol India 2010; 58: 429-435
  • 10 Wolff JE, Sajedi M, Brant R, Coppes MJ, Egeler RM. Choroid plexus tumours. Br J Cancer 2002; 87: 1086-1091
  • 11 Fitzpatrick LK, Aronson LJ, Cohen KJ. Is there a requirement for adjuvant therapy for choroid plexus carcinoma that has been completely resected?. J Neurooncol 2002; 57: 123-126
  • 12 Berger C, Thiesse P, Lellouch-Tubiana A, Kalifa C, Pierre-Kahn A, Bouffet E. Choroid plexus carcinomas in childhood: clinical features and prognostic factors. Neurosurgery 1998; 42: 470-475
  • 13 Juretschke FR, Güresir E, Marquardt G , et al. Trigonal and peritrigonal lesions of the lateral ventricle-surgical considerations and outcome analysis of 20 patients. Neurosurg Rev 2010; 33: 457-464
  • 14 Wrede B, Liu P, Ater J, Wolff JE. Second surgery and the prognosis of choroid plexus carcinoma—results of a meta-analysis of individual cases. Anticancer Res 2005; 25: 4429-4433
  • 15 Wolff JE, Sajedi M, Coppes MJ, Anderson RA, Egeler RM. Radiation therapy and survival in choroid plexus carcinoma. Lancet 1999; 353: 2126
  • 16 Cheuk DK, Lee TL, Chiang AK, Ha SY, Chan GC. Autologous hematopoietic stem cell transplantation for high-risk brain tumors in children. J Neurooncol 2008; 86: 337-347
  • 17 Lafay-Cousin L, Mabbott DJ, Halliday W , et al. Use of ifosfamide, carboplatin, and etoposide chemotherapy in choroid plexus carcinoma. J Neurosurg Pediatr 2010; 5: 615-621
  • 18 Araki K, Aori T, Takahashi JA , et al. [A case report of choroid plexus carcinoma]. No Shinkei Geka 1997; 25: 853-857
  • 19 Mazloom A, Wolff JE, Paulino AC. The impact of radiotherapy fields in the treatment of patients with choroid plexus carcinoma. Int J Radiat Oncol Biol Phys 2010; 78: 79-84
  • 20 Berger C, Thiesse P, Lellouch-Tubiana A, Kalifa C, Pierre-Kahn A, Bouffet E. Choroid plexus carcinomas in childhood: clinical features and prognostic factors. Neurosurgery 1998; 42: 470-475